Life Science News
Latest updates from the biotech and pharma world
Otsuka gains approval for first-of-its-kind treatment against rare kidney disease
CMS sets 2027 Medicare prices for Wegovy, Trelegy and 13 other drugs
Novartis wins approval to use SMA gene therapy in older patients
Gilead scoops up a preclinical cancer program
How do Big Pharma employees rate their CEOs?
Kelun, Merck tout ADC as potential first-line treatment in lung cancer
Bayer’s experimental blood-thinner notches trial win in stroke prevention
#Asundexian Phase#prevention Asundexian#study results#clinical setbacks#Phase
Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies
#Novo Nordisk#watched Alzheimer#misses goal#heart health#combat neurodegeneration
FDA probes effects of Takeda rare disease drug after patient death
#FDA probes#Takeda rare#neutralizing antibodies#probes effects#rare disease
Biogen strikes deal with Versant-backed biotech to expand immune portfolio
#Dayra Therapeutics#Versant-backed biotech#portfolio Newly#Newly launched#launched Dayra
APOE4 and CRISPR are reframing Alzheimer’s Risk
#reframing Alzheimer#CRISPR brings#slowing Alzheimer#brings hope#CRISPR
Eli Lilly becomes first drugmaker to hit $1 trillion in market value
#Eli Lilly#drugmaking peers#pharmaceutical company#success developing#developing medicines
FDA tests new program to speed drugmaker talks; Bezos-linked AI startup raises $106M
#quick clarifications#FDA tests#drugmaker talks#speed drugmaker#agency staff
GSK, Anaptysbio sue each other over Jemperli revenue
#Jemperli revenue#royalty business#cancer immunotherapy#Anaptysbio sue#Anaptysbio seeks
A brain biotech’s top drug fails against MS
#Contineum Therapeutics#Therapeutics dipped#late Thursday#piqued Johnson#brain biotech
Moderna secures $1.5B lifeline as it looks to break even in 2028
#Moderna secures#day event#disease programs#analyst day#invest revenue
Roche pill notches win in early breast cancer - BioPharma Dive
#Roche pill#BioPharma Dive#pill notches#notches win#early breast
Roche’s MS tablet scores in late-stage studies - BioPharma Dive
#BioPharma Dive#tablet scores#Dive Roche#late-stage studies#Dive
Roche taps an AI specialist to craft new brain drugs - BioPharma Dive
#Roche taps#BioPharma Dive#Dive Roche#brain drugs#Dive